Guggenheim raises Revolution stock target on pipeline update
RVMD Stock | USD 43.29 0.32 0.74% |
About 68% of Revolution Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that many traders are alarmed. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
Revolution |
Guggenheim raises Revolution stock target on pipeline update
Read at investing.com
Revolution Medicines Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Revolution Medicines Fundamental Analysis
We analyze Revolution Medicines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Revolution Medicines is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Revolution Medicines Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revolution Medicines stock to make a market-neutral strategy. Peer analysis of Revolution Medicines could also be used in its relative valuation, which is a method of valuing Revolution Medicines by comparing valuation metrics with similar companies.
Peers
Revolution Medicines Related Equities
STOK | Stoke Therapeutics | 1.71 | ||||
RNA | Avidity Biosciences | 1.14 | ||||
AKRO | Akero Therapeutics | 1.08 | ||||
BPMC | Blueprint Medicines | 3.11 | ||||
PTGX | Protagonist Therapeutics | 4.10 | ||||
NRIX | Nurix Therapeutics | 4.44 | ||||
BDTX | Black Diamond | 6.40 | ||||
GLUE | Monte Rosa | 7.40 | ||||
KYMR | Kymera Therapeutics | 7.66 | ||||
AGIO | Agios Pharm | 8.23 | ||||
PASG | Passage Bio | 8.96 | ||||
CCCC | C4 Therapeutics | 9.63 | ||||
SANA | Sana Biotechnology | 11.52 |
Complementary Tools for Revolution Stock analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |